Apart from TGF-β, a number of experimental trials have demonstrated the efficacy of angiotensin-II receptor agonists, such as losartan, which are commonly used to treat hypertension, and have been shown to be effective in the treatment of hypertension. This evidence concerns the gene TGFB1 and Hypertension.